US 7919496
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
granted A61KA61K31/381A61K31/41
Quick answer
US patent 7919496 (Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes) held by Xenon Pharmaceuticals Inc. expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/381, A61K31/41, A61K31/415, A61P